Asthma control in patients with asthma and allergic rhinitis receiving add-on montelukast therapy for 12 months: A retrospective observational study

Current Medical Research and Opinion

Volumn 23, Issue 4, 2007, Pages 721-730

  Borderias, Luis ^a   Mincewicz, Grzegorz ^b   Paggiaro, Pier Luigi ^c   Guilera, Magda ^d   Kocevar, Vasilisa Sazonov ^e   Taylor, Stephanie D ^e   Badia, Xavier ^d  

^a HOSPITAL SAN JORGE   (Spain)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c UNIVERSITY OF PISA   (Italy)

^d Health Outcomes Research Europe   (Spain)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Allergic rhinitis; Asthma control; Montelukast; Resource use

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; MONTELUKAST;

ADD ON THERAPY; ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE CONTROL; EMERGENCY WARD; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POLAND; RETROSPECTIVE STUDY; SPAIN; TREATMENT DURATION; TREATMENT OUTCOME;

ACETATES; ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MALE; MIDDLE AGED; QUINOLINES; RETROSPECTIVE STUDIES; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME;

EID: 34247378140     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X167606     Document Type: Article

References (41)

1. Yawn BP, Yunginger JW, Wollan PC, et al. Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. J Allergy Clin Immunol 1999;103:54-9
2. Togias A. Unique mechanistic features of allergic rhinitis. J Allergy Clin Immunol 2000;105:S599-S604
3. Kaspsali T, Horowitz E, Diomer F, et al. Rhinitis is ubiquitous in allergic asthmatics. J Allergy Clin Immunol 1997;99:S138
4. Greisner W, Settipane R Settipane G. Co-existence of asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Asthma Proc 1998;19:185-8
5. Bousquet J, Van Cauwenberge P, Khaltaev N [ARIA Workshop Group; World Health Organization], Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108 (Suppl 5): S147-S334
6. Crimi E, Milanses M, Oddera S, et al. Inflammatory and mechanical factors of allergen-induced bronchoconstriction in mild asthma and rhinitis. J Appl Physiol 2001;91:1029-34
7. Chanez P, Vignola A, Vic P, et al. Comparison between nasal and bronchial inflammation in asthmatic and control subjects. Am J Respir Crit Care Med 1999;159:558-95
8. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asdima. New Engl J Med 1990;323:1033-9
9. Gaga M, Lambrou P, Papageorgiou N, et al. Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin Exp Allergy 2000;30:663-9
10. Djukanovic R, Lai C, Wilson J, et al. Bronchial mucosa manifestation of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur Respir J 1992;5:538-44
11. Halpern MT, Schmier JK, Richner R, et al. Allergic rhinitis: a potential cause of increased asthma medication use, costs and morbidity. J Asthma 2004;41:117-26
12. Price DB, Zhang Q, Sazonov Kocevar V, et al. Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults. Clin Exp Allergy 2005;35:282-7
13. Bousquet J, Gaugris S, Sazonov Kocevar V, et al. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the improving asthma control trial. Clin Exp Allergy 2005;35:723-7
14. Corren J, Adinoff AD, Buchmeier AS, et al. Nasal beclomethasone prevents the seasonal increase in bronchial respons-iveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992;90:250-6
15. Wood RA, Eggleston PA. The effects of intranasal steroids on nasal and pulmonary responses to cat exposure. Am J Respir Crit Care Med 1995;151:315-20
16. Crystal-Peters J, Neslusan C, Crown WH, et al. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002;109:57-62
17. Henderson Jr WR. The role of leukotrienes in inflammation. Ann Intern Med 1994;121:684-97
18. Creticos P, Peters S, Adkinson NJ, et al. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. New Engl J Med 1984;310:1626-30
19. Okuda M, Watase T, Mezawa A, et al. The role of leukotriene D4 in allergic rhinitis. Ann Allergy 1988;60:537-40
20. Knapp HR, Murray JJ. Leukotrienes as mediators of nasal inflammation. Adv Prostaglandins Thromboxane Leukot Res 1994;22:279-88
21. Merck & Co., Inc. Singulair®, Prescribing Information. September 2006. http://www.merck.eom/product/usa/pi_circulars/s/singulau/singulair_pi.pdf
22. Baena-Cagnani CE, Berger WE, DuBuske LM, et al. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol 2003;130:307-13
23. Philip G, Nayak AS, Berger WE, et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 2004;20:1549-58
24. Price DB, Swern A, Tozzi CA, et al. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy 2006;61:737-42
25. Global initiative for asthma guidelines. Available at: http://www.ginasthma.com/GuidelineList.asp?l1=2&l2=1 [last accessed 22 December 2006]
26. Allergic rhinitis and its impact on asthma. Available at: http://www.whiar.org/ [last accessed 22 December 2006]
27. Israel E, Chervinsky PS, Friedman B, et al. Effects of montelukast and beclomethasone on airway function and asthma control. J Allergy Clin Immunol 2002;110:847-54
28. Baumgartner RA, Martinez G, Edelman JM, et al. Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone. Eur Respir J 2003;21:123-8
29. Bjermer L, Bisgaard H, Bousquet J, et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. Br Med J 2003;327:891-6
30. Naureckas E, Dukic V, Bao X, Rathouz P. Short-acting beta-agonist prescription fills as a marker for asthma morbidity. Chest 2005;128:602-8
31. Sazonov-Kocevar V, Laforest L, Travier N, et al. Asthma and allergy medication use and costs among pediatric primary care patients on asthma controller therapy. Pediatr Allergy Immunol 2006;17:620-8
32. Anstatt D, Allen-Ramey FC, Korelitz JJ, et al. Asthma control with montelukast or salmeterol as add-on therapy to inhaled corticosteroid treatment of asthma. Chest 2003; 124:94S
33. Price D, Wolfe S. Montelukast: clinical and cost effectiveness in primary care. Am J Respir Crit Care Med 1999; 159:A640
34. Price DB, Ben-Joseph RH, Zhang Q. Changes in asthma drug tiierapy costs for patients receiving chronic montelukast therapy in the U.K. Respir Med 2001;95:83-9
35. Barnes N, Thomas M, Price D, et al. The national montelukast survey. J Allergy Clin Immunol 2005;115:47-54
36. Zhang Q, Thomas M, Wisniewski T, et al. Treatment and outcomes in patients widi asthma and allergic rhinitis in the United Kingdom. Int Arch Allergy Immunol 2006;142:318-28
37. Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol 2005;34:215-20
38. Cerveri I, Locatelli F, Zoia MC, et al. International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1999;14:288-94
39. Janson C, de Marco R, Accordini S, et al. Changes in the use of anti-asthmatic medication in an international cohort. Eur Respir J 2005;26:1047-55
40. Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004;114:1288-93
41. Berggren F. Assessing the use of retrospective databases in conducting economic evaluations of drugs: the case of asthma. Pharmacoeconomics 2004;22:771-91